Neurostim®

The number of National Certificate of Registration: 77.99.23.3.U.1361.3.07 dated March 1, 2007

Specification number: TU 9283-001-59230155-07

Formulation: “Dienai C”  (salmon roe extract (low-molecular DNA), potato starch, microcrystalline cellulose, sodium chloride, polyethylene glycol), “Tinrostim”^® (hydrolysate of squid ganglia)l.

Pharmacological group: refers to the group of food supplements-parapharmaceutics.

Toxicologic characteristics: This preparation refers to class 4 (“low-hazard substances”) according to Russian Interstate Standard 12.1.007-76. No toxic or side effects were revealed after the experimental intragastral administration to animals.

Indications:

1. To patients after craniocerebral injury or stroke

2. To patients with signs of demyelinating diseases and slow neuroinfections.

3. For prevention and biocorrection of Alzheimer's disease.

4. To healthy people for improving learning ability, response speed, efficiency of intellectual work.

5. To healthy people for overcoming asthenia, chronic fatigue, depressions; prevention and overcoming of intoxications.

6. To children with infantile cerebral paralysis and distracted attention syndrome.

7. To patients with acute and chronic eye inflammation (conjunctivitis, keratitis).

Administration method and dosage: orally, 1 capsule three times a day during the meal to adults and children older than 14 years. Administration duration is 3 weeks.

Contraindications: individual intolerance for preparation components, pregnancy, lactation.

Pharmaceutical form: 0.5 g capsules, 45 per package.

Storing conditions: store in a dry place away from light, out of the reach of children at temperature up to 25 oC.

Expiration date: 2 years from the date of manufacturing.

Prescription conditions: No prescription required.

Manufacturer: Siberian Center for Pharmacology and Biotechnology, closed joint-stock company (Novosibirsk, Russian Federation).